Immunotherapy of myeloma: BCMA/SLAMF7 CAR T-cells & BiTEs
Multiple myeloma (MM) is at the forefront of immunotherapeutic developments, including T-cell therapies and bispecific antibodies. Here, our expert panel discuss BCMA and SLAMF7 targeting CAR T-cells,...
Author: VJHemOnc
Added: 09/14/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts